244 results
Page 8 of 13
424B5
81p s4ftzw
13 Oct 10
Prospectus supplement for primary offering
12:00am
8-K
2u3c6txi0a2nkalm
25 Aug 10
Departure of Directors or Certain Officers
12:00am
424B5
09p l2idtm5fjc
18 Jun 10
Prospectus supplement for primary offering
12:00am
424B5
bk5zjrag 1x
16 Jun 10
Prospectus supplement for primary offering
12:00am
424B3
t88geb
15 Jun 10
Prospectus supplement
12:00am
8-K
EX-99.1
36uycq 8c55k7sg0
28 Apr 10
Discovery Labs Provides Updates on Surfaxin®, Other Key Programs and First Quarter 2010 Financial Results
12:00am
424B5
k6pzg8
28 Apr 10
Prospectus supplement for primary offering
12:00am
424B5
pvn 6j4p64g
19 Feb 10
Prospectus supplement for primary offering
12:00am
424B5
xn7q9x
17 Feb 10
Prospectus supplement for primary offering
12:00am
8-K
EX-99.2
t17wt0dt
4 Nov 09
Discovery Labs’ Third Quarter 2009
12:00am
8-K
rmgxzqdjdsfqd48
4 Nov 09
Discovery Labs’ Third Quarter 2009
12:00am
8-K
EX-99.1
5qupxe7 4mi896
30 Sep 09
Discovery Labs and FDA Establish Path for Potential SURFAXIN Approval
12:00am
8-K
EX-99.1
h625lwy
11 Sep 09
Other Events
12:00am
8-K
EX-99.1
wzzhvzs3
4 Sep 09
Discovery Labs Announces Date of 2009 Annual Shareholder Meeting
12:00am
8-K
EX-99.1
an04m5luk7vv2e095lu
19 Aug 09
Discovery Labs Announces Resignation of CEO Robert J. Capetola, Ph.D.; W. Thomas Amick, Chairman of the Board, Appointed Interim CEO
12:00am